Quarry LP Exelixis, Inc. Transaction History
Quarry LP
- $461 Billion
- Q1 2025
A detailed history of Quarry LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Quarry LP holds 2,000 shares of EXEL stock, worth $92,520. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,000
Previous 40
4900.0%
Holding current value
$92,520
Previous $1.33 Million
5443.54%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
606Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.55 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.33 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1.04 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$686 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$545 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...